| BOXX Alpha Architect 1-3 MNTH Box | 9.25% | 318,120 | $33.9M | New |
| ROIV Roivant Sciences Ltd. | 8.03% | 2,791,870 | $29.4M | Add +122.2% |
| ALNY Alnylam Pharmaceuticals Inc. | 7.35% | 180,145 | $26.9M | Add +1796.3% |
| PTGX Protagonist Therapeutics Inc. | 6.21% | 785,655 | $22.7M | Add +291.1% |
| CYTK Cytokinetics Inc. | 6.12% | 319,510 | $22.4M | Add +247.0% |
| KROS Keros Therapeutics Inc. | 6.11% | 338,243 | $22.4M | Reduce -50.9% |
| RPRX Royalty Pharma PLC Class A | 5.98% | 721,301 | $21.9M | Reduce -45.4% |
| BBIO Bridgebio Pharma Inc. | 4.64% | 549,804 | $17.0M | Add +197.0% |
| MACK Merrimack Pharmaceuticals Inc. | 3.64% | 902,350 | $13.3M | Add +64.2% |
| ASND Ascendis Pharma A/S | 2.01% | 48,584 | $7.3M | Add +5.9% |
| ABUS Arbutus Biopharma Corp. | 1.46% | 2,074,183 | $5.4M | Reduce -40.2% |
| AVROBIO INC | 1.38% | 3,954,857 | $5.1M | Add +7786.5% |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 1.35% | 31,505 | $4.9M | Add +1453.5% |
| ALKS Alkermes PLC | 1.16% | 156,600 | $4.2M | New |
| BBOT Bridgebio Oncology Therapeut filed as HELIX ACQUISITION CORP II | 1.15% | 403,500 | $4.2M | New |
| SRPT Sarepta Therapeutics Inc. | 1.10% | 31,105 | $4.0M | Add +285.8% |
| EDR Endeavor Group Hold Class A | 1.09% | 155,250 | $4.0M | Add +6110.0% |
| ACHV Achieve Life Sciences Inc. | 1.09% | 875,000 | $4.0M | New |
| FUSN Fusion Pharmaceuticals Inc. | 1.03% | 177,200 | $3.8M | New |
| ABSI Absci Corp. | 0.91% | 586,984 | $3.3M | New |
| EWTX Edgewise Therapeutics Inc. | 0.90% | 180,911 | $3.3M | New |
| FULC Fulcrum Therapeutics Inc. | 0.88% | 339,825 | $3.2M | Reduce -46.7% |
| QTTB Q32 Bio Inc. | 0.87% | 187,567 | $3.2M | New |
| APLT Applied Therapeutics Inc. | 0.85% | 456,588 | $3.1M | New |
| BIL SS SPDR BB 1-3M T-Bill ETF | 0.81% | 32,500 | $3.0M | Add +1.6% |
| PFE Pfizer Inc. | 0.81% | 106,342 | $3.0M | Add +511.2% |
| VUSB Vanguard Ultra Short Bond Et | 0.75% | 55,206 | $2.7M | Add +10.0% |
| JPST JPMorgan Ultra-Short Income | 0.74% | 54,000 | $2.7M | Add +10.2% |
| SHV iShares 0-1 Year Treasury Bo | 0.74% | 24,500 | $2.7M | No change |
| SLDB Solid Biosciences Inc. | 0.74% | 203,204 | $2.7M | Add +20220.4% |
| USFR Wisdomtree Floating Rate Tre | 0.73% | 53,000 | $2.7M | Reduce -5.4% |
| CLRB Cellectar Biosciences Inc. | 0.70% | 642,541 | $2.6M | Reduce -53.4% |
| OABI Omniab Inc. | 0.67% | 451,485 | $2.4M | Reduce -5.6% |
| CNTA Centessa Pharmaceuticals Ltd. | 0.64% | 206,856 | $2.3M | New |
| REGN Regeneron Pharmaceuticals | 0.60% | 2,300 | $2.2M | New |
| IBIO Ibio Inc. | 0.60% | 600,000 | $2.2M | New |
| CTVA Corteva Inc. | 0.59% | 37,400 | $2.2M | Reduce -35.5% |
| XAIR Beyond Air Inc. | 0.57% | 1,204,820 | $2.1M | New |
| IMVT Immunovant Inc. | 0.54% | 60,763 | $2.0M | Reduce -54.7% |
| LGND Ligand Pharmaceuticals | 0.53% | 26,800 | $2.0M | New |
| ULST SS Ultra Short TM Bond ETF | 0.53% | 47,684 | $1.9M | Reduce -22.2% |
| SYRE Spyre Therapeutics Inc. | 0.51% | 49,500 | $1.9M | Add +668.6% |
| SDGR Schrodinger Inc. | 0.47% | 63,586 | $1.7M | Add +3079.3% |
| SPRO Spero Therapeutics Inc. | 0.44% | 926,929 | $1.6M | Reduce -13.2% |
| QURE Uniqure NV | 0.42% | 292,850 | $1.5M | New |
| APLS Apellis Pharmaceuticals Inc. | 0.41% | 25,700 | $1.5M | New |
| LLY Eli Lilly & Co. | 0.40% | 1,865 | $1.5M | New |
| TEVA Teva Pharmaceutical-SP ADR | 0.39% | 101,626 | $1.4M | Reduce -8.7% |
| NGM NGM Biopharmaceuticals Inc. | 0.35% | 816,581 | $1.3M | New |
| VKTX Viking Therapeutics Inc. | 0.32% | 14,401 | $1.2M | Reduce -94.3% |
| KNSA Kiniksa Pharmaceuticals Ltd. | 0.32% | 59,700 | $1.2M | Reduce -43.1% |
| NVNO Envveno Medical Corporation | 0.30% | 201,728 | $1.1M | New |
| ARVN Arvinas Inc. | 0.30% | 26,200 | $1.1M | New |
| DCTH Delcath Systems Inc. | 0.29% | 218,973 | $1.0M | Reduce -5.3% |
| CERE Cerevel Therapeutics Holding | 0.28% | 24,259 | $1.0M | Reduce -78.1% |
| ANGO Angiodynamics Inc. | 0.25% | 153,362 | $900K | Add +15.3% |
| SLN Silence Therapeutics PLC-ADR | 0.24% | 40,090 | $866K | Add +21000.0% |
| GOSS Gossamer Bio Inc. | 0.24% | 732,628 | $865K | Add +2.8% |
| GLST Global Star Acquisition Class A | 0.23% | 80,000 | $857K | No change |
| VYGR Voyager Therapeutics Inc. | 0.23% | 91,534 | $852K | Reduce -50.8% |
| CATX Perspective Therapeutics Inc. | 0.22% | 676,725 | $805K | Add +1503.6% |
| KVAUF Keen Vision Acquisition Corp. | 0.22% | 75,000 | $788K | No change |
| ATNM Actinium Pharmaceuticals Inc. | 0.21% | 100,000 | $783K | New |
| KPRX Kiora Pharmaceuticals Inc. | 0.21% | 1,100,000 | $777K | New |
| ACASTI PHARMA INC | 0.20% | 217,381 | $745K | Add +529.5% |
| MORF Morphic Holding Inc. | 0.19% | 19,701 | $693K | New |
| KYMR Kymera Therapeutics Inc. | 0.18% | 16,000 | $643K | New |
| CRBP Corbus Pharmaceuticals Holdi | 0.17% | 16,000 | $628K | New |
| TXMD Therapeuticsmd Inc. | 0.17% | 272,160 | $623K | No change |
| WST West Pharmaceutical Services | 0.16% | 1,500 | $594K | New |
| INDV Indivior Ltd. | 0.16% | 27,601 | $591K | Add +14.5% |
| RYTM Rhythm Pharmaceuticals Inc. | 0.15% | 12,400 | $537K | New |
| TMTC TMT Acquisition Corp. Class A | 0.15% | 50,000 | $535K | No change |
| JANX Janux Therapeutics Inc. | 0.14% | 14,000 | $527K | New |
| NRIX Nurix Therapeutics Inc. | 0.14% | 35,608 | $523K | New |
| YEAR AB Ultra Short Income ETF filed as AB ACTIVE ETFS INC | 0.14% | 10,000 | $505K | No change |
| STVN Stevanato Group SPA | 0.14% | 15,500 | $498K | New |
| PULS Pgim Ultra Short Bond ETF | 0.14% | 10,000 | $497K | No change |
| VTGN Vistagen Therapeutics Inc. | 0.13% | 89,938 | $475K | Reduce -63.4% |
| AEROVATE THERAPEUTICS INC | 0.13% | 15,900 | $470K | New |
| TYRA Tyra Biosciences Inc. | 0.13% | 28,300 | $464K | New |
| ARYD Arya Sciences Acquisition-A | 0.13% | 40,930 | $460K | New |
| EQ Equillium Inc. | 0.13% | 198,775 | $459K | Add +2958.1% |
| INTELLIGENT BIO SOLUTIONS IN | 0.12% | 108,250 | $457K | New |
| APGE Apogee Therapeutics Inc. | 0.11% | 6,000 | $399K | New |
| MIST Milestone Pharmaceuticals Inc. | 0.10% | 202,460 | $362K | New |
| BCYC Bicycle Therapeutics PLC-ADR | 0.10% | 14,430 | $359K | Reduce -80.7% |
| ZLAB Zai Lab Ltd.-ADR | 0.10% | 22,000 | $352K | Add +10.0% |
| GH Guardant Health Inc. | 0.10% | 17,000 | $351K | New |
| VYNE THERAPEUTICS INC | 0.09% | 110,091 | $338K | New |
| CTMX Cytomx Therapeutics Inc. | 0.09% | 155,000 | $338K | New |
| OAKU Oak Woods Acquisition Corp. Class A | 0.09% | 30,000 | $323K | No change |
| SCRM Screaming Eagle Acq Class A | 0.09% | 30,000 | $321K | No change |
| ALEC Alector Inc. | 0.09% | 52,500 | $316K | New |
| MLYS Mineralys Therapeutics Inc. | 0.08% | 24,000 | $310K | New |
| JVSAU Jvspac Acquisition Corp. | 0.08% | 30,000 | $309K | New |
| GOOGL Alphabet Inc. Class A | 0.08% | 2,000 | $302K | New |
| SPRB Spruce Biosciences Inc. | 0.08% | 365,216 | $287K | New |
| CNTX Context Therapeutics Inc. | 0.08% | 205,934 | $284K | New |
| SNY Sanofi-ADR | 0.07% | 5,500 | $267K | New |
| TRML Tourmaline Bio Inc. | 0.07% | 11,560 | $265K | New |
| CCOI Cogent Communications Holdin | 0.07% | 4,000 | $261K | New |
| IROHU Iron Horse Acquisitions Corp. | 0.07% | 25,000 | $255K | No change |
| ZROZ PIMCO 25+ YR Zero CPN US Tif | 0.06% | 3,000 | $238K | New |
| VERU Veru Inc. | 0.06% | 336,072 | $235K | Reduce -32.8% |
| OPCH Option Care Health Inc. | 0.06% | 7,000 | $235K | New |
| AQN Algonquin Power & Utilities | 0.06% | 37,000 | $234K | Reduce -26.0% |
| ABVX Abivax SA-ADR | 0.06% | 15,000 | $215K | New |
| KEZAR LIFE SCIENCES INC | 0.06% | 236,623 | $213K | New |
| KTTA Pasithea Therapeutics Corp. | 0.05% | 27,696 | $201K | New |
| TLT iShares 20+ Year Treasury BD | 0.05% | 2,000 | $189K | New |
| WVE Wave Life Sciences Ltd. | 0.05% | 30,000 | $185K | New |
| IMTX Immatics NV | 0.05% | 16,200 | $170K | Reduce -26.4% |
| GLRE Greenlight Capital Re Ltd. Class A | 0.05% | 13,385 | $167K | Reduce -60.7% |
| AIEV Thunder Power Holdings Inc. filed as FEUTUNE LIGHT ACQUISITION CO | 0.04% | 15,000 | $163K | No change |
| ABT Abbott Laboratories | 0.04% | 1,400 | $159K | New |
| NVEI Nuvei Corp.-Subordinate VTG | 0.04% | 5,000 | $158K | New |
| BKHAU Black Hawk Acquisition Corp. | 0.04% | 15,000 | $152K | New |
| CABA Cabaletta Bio Inc. | 0.04% | 8,900 | $152K | New |
| MLTX Moonlake Immunotherapeutics | 0.04% | 3,000 | $151K | New |
| PRTA Prothena Corp. PLC | 0.04% | 5,988 | $148K | Reduce -1.9% |
| PCVX Vaxcyte Inc. | 0.04% | 2,000 | $137K | Add +1900.0% |
| MCK McKesson Corp. | 0.04% | 250 | $134K | New |
| GHRS GH Research PLC | 0.04% | 12,583 | $134K | New |
| AVTX Avalo Therapeutics Inc. | 0.04% | 6,000 | $131K | New |
| IONS Ionis Pharmaceuticals Inc. | 0.03% | 2,900 | $126K | New |
| TSHA Taysha Gene Therapies Inc. | 0.03% | 43,500 | $125K | Reduce -79.2% |
| FORTE BIOSCIENCES INC | 0.03% | 170,510 | $119K | New |
| KALV Kalvista Pharmaceuticals Inc. | 0.03% | 10,000 | $119K | New |
| EXAS Exact Sciences Corp. | 0.03% | 1,700 | $117K | New |
| OGN Organon & Co. | 0.03% | 6,000 | $113K | New |
| AMLX Amylyx Pharmaceuticals Inc. | 0.03% | 38,858 | $110K | Reduce -49.9% |
| JD Jd.com Inc.-ADR | 0.03% | 4,000 | $110K | New |
| FORL Four Leaf Acquisition Cor-A | 0.03% | 10,000 | $107K | No change |
| GPCR Structure Therapeutics Inc. | 0.03% | 2,500 | $107K | Reduce -37.5% |
| SLRN Acelyrin Inc. | 0.03% | 15,021 | $101K | Add +114.6% |
| LBPH Longboard Pharmaceuticals Inc. | 0.03% | 4,580 | $99K | Add +472.5% |
| KCGI Kensington Capital Acq-A | 0.03% | 9,000 | $98K | No change |
| LEXX Lexaria Bioscience Corp. | 0.03% | 26,626 | $97K | Add +1537.5% |
| NXTC Nextcure Inc. | 0.03% | 43,014 | $96K | Reduce -28.8% |
| BLCO Bausch + Lomb Corp. | 0.03% | 5,300 | $92K | Add +51.4% |
| CGON CG Oncology Inc. | 0.02% | 2,050 | $90K | New |
| MO Altria Group Inc. | 0.02% | 2,000 | $87K | Reduce -66.7% |
| MITK Mitek Systems Inc. | 0.02% | 5,600 | $79K | Reduce -26.3% |
| NNAGU 99 Acquisition Group Inc. | 0.02% | 7,500 | $79K | No change |
| AITRU AI Transportation Acquisitio | 0.02% | 7,500 | $78K | No change |
| IOVA Iovance Biotherapeutics Inc. | 0.02% | 5,000 | $74K | No change |
| ACET Adicet Bio Inc. | 0.02% | 31,229 | $73K | New |
| HHH Howard Hughes Holdings Inc. | 0.02% | 1,000 | $73K | Reduce -66.7% |
| JSPR Jasper Therapeutics Inc. | 0.02% | 2,406 | $71K | New |
| TGTX TG Therapeutics Inc. | 0.02% | 4,361 | $66K | New |
| ATXS Astria Therapeutics Inc. | 0.02% | 4,652 | $65K | Reduce -97.6% |
| FDMT 4D Molecular Therapeutics Inc. | 0.02% | 2,000 | $64K | New |
| GDX Vaneck Gold Miners ETF | 0.02% | 2,000 | $63K | Reduce -33.3% |
| LNTH Lantheus Holdings Inc. | 0.02% | 1,000 | $62K | New |
| EVO Evotec SE - Spon ADR | 0.02% | 7,700 | $60K | New |
| KSS Kohls Corp. | 0.02% | 2,000 | $58K | No change |
| IRON Disc Medicine Inc. | 0.02% | 896 | $56K | New |
| KRYS Krystal Biotech Inc. | 0.01% | 300 | $53K | New |
| RGNX Regenxbio Inc. | 0.01% | 2,500 | $53K | New |
| KWEB Kranesh Csi China Internet | 0.01% | 2,000 | $53K | No change |
| FIBROGEN INC | 0.01% | 21,350 | $50K | New |
| OVID Ovid Therapeutics Inc. | 0.01% | 16,446 | $50K | Add +24.2% |
| IKENA ONCOLOGY INC | 0.01% | 35,000 | $50K | New |
| AMPY Amplify Energy Corp. | 0.01% | 7,081 | $47K | No change |
| PHVS Pharvaris NV | 0.01% | 2,000 | $46K | New |
| UCTT Ultra Clean Holdings Inc. | 0.01% | 1,000 | $46K | New |
| AKRO Akero Therapeutics Inc. | 0.01% | 1,807 | $46K | Reduce -88.7% |
| VRDN Viridian Therapeutics Inc. | 0.01% | 2,550 | $45K | New |
| ELEV Elevation Oncology Inc. | 0.01% | 8,629 | $44K | New |
| PYXS Pyxis Oncology Inc. | 0.01% | 10,000 | $43K | New |
| ARQT Arcutis Biotherapeutics Inc. | 0.01% | 4,254 | $42K | Reduce -98.5% |
| DNLI Denali Therapeutics Inc. | 0.01% | 2,000 | $41K | New |
| ADVM Adverum Biotechnologies Inc. | 0.01% | 2,800 | $40K | New |
| MRK Merck & Co. Inc. | 0.01% | 300 | $40K | Reduce -99.4% |
| STOK Stoke Therapeutics Inc. | 0.01% | 2,900 | $39K | New |
| MX Magnachip Semiconductor Corp. | 0.01% | 7,000 | $39K | No change |
| IGMS Igm Biosciences Inc. | 0.01% | 4,000 | $39K | New |
| ASLAN PHARMACEUTICALS LTD | 0.01% | 59,393 | $37K | New |
| ETNB 89BIO Inc. | 0.01% | 3,060 | $36K | Add +611.6% |
| HOOKIPA PHARMA INC | 0.01% | 50,000 | $36K | New |
| NGNE Neurogene Inc. | 0.01% | 661 | $34K | Reduce -87.8% |
| RLYB Rallybio Corp. | 0.01% | 17,942 | $33K | New |
| TERN Terns Pharmaceuticals Inc. | 0.01% | 5,000 | $33K | Reduce -61.6% |
| AMPH Amphastar Pharmaceuticals Inc. | 0.01% | 700 | $31K | New |
| LQDA Liquidia Corp. | 0.01% | 2,000 | $30K | New |
| DSGN Design Therapeutics Inc. | 0.01% | 7,200 | $29K | Add +260.0% |
| QUINCE THERAPEUTICS INC | 0.01% | 26,829 | $28K | New |
| SVRA Savara Inc. | 0.01% | 5,600 | $28K | New |
| VTYX Ventyx Biosciences Inc. | 0.01% | 5,000 | $28K | Reduce -61.5% |
| PRGO Perrigo Co. PLC | 0.01% | 800 | $26K | New |
| VYX NCR Voyix Corp. | 0.01% | 2,000 | $25K | No change |
| ANAB Anaptysbio Inc. | 0.01% | 1,000 | $23K | New |
| ONCT Oncternal Therapeutics Inc. | 0.01% | 2,472 | $22K | New |
| CMPX Compass Therapeutics Inc. | 0.01% | 10,206 | $20K | New |
| ZYME Zymeworks Inc. | 0.01% | 1,900 | $20K | New |
| NATL NCR Atleos Corp. | 0.01% | 1,000 | $20K | No change |
| ARWR Arrowhead Pharmaceuticals Inc. | 0.00% | 600 | $17K | Add +100.0% |
| PMVP PMV Pharmaceuticals Inc. | 0.00% | 10,000 | $17K | New |
| AZN Astrazeneca PLC-Spons ADR | 0.00% | 200 | $14K | New |
| SPLP Steel Partners Holdings LP | 0.00% | 341 | $14K | No change |
| NVO Novo-Nordisk A/S-Spons ADR | 0.00% | 100 | $13K | Reduce -98.4% |
| XERS Xeris Biopharma Holdings Inc. | 0.00% | 5,149 | $11K | New |
| BHVN Biohaven Ltd. | 0.00% | 200 | $11K | New |
| AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 2,000 | $10K | New |
| ACAD Acadia Pharmaceuticals Inc. | 0.00% | 500 | $9K | New |
| MRVI Maravai Lifesciences Hldgs-A | 0.00% | 1,000 | $9K | New |
| DYN Dyne Therapeutics Inc. | 0.00% | 297 | $8K | New |
| TARA Protara Therapeutic Inc. | 0.00% | 2,000 | $8K | Reduce -8.8% |
| SRZN Surrozen Inc. | 0.00% | 450 | $7K | New |
| BOLT Bolt Biotherapeutics Inc. | 0.00% | 5,000 | $7K | New |
| BLUEBIRD BIO INC | 0.00% | 5,000 | $6K | New |
| MASI Masimo Corp. | 0.00% | 38 | $6K | Reduce -34.5% |
| TSVT 2SEVENTY Bio Inc. | 0.00% | 1,000 | $5K | No change |
| ADXN Addex Therapeutics Ltd. | 0.00% | 390 | $5K | New |
| BYND Beyond Meat Inc. | 0.00% | 577 | $5K | New |
| GERN Geron Corp. | 0.00% | 1,295 | $4K | Reduce -92.5% |
| ICHR Ichor Holdings Ltd. | 0.00% | 108 | $4K | New |
| CALC Calcimedica Inc. | 0.00% | 781 | $3K | New |
| RLMD Relmada Therapeutics Inc. | 0.00% | 601 | $3K | Reduce -99.0% |
| TLIS Talis Biomedical Corp. | 0.00% | 300 | $3K | New |
| KPTI Karyopharm Therapeutics Inc. | 0.00% | 1,479 | $2K | New |
| TVTX Travere Therapeutics Inc. | 0.00% | 100 | $771 | No change |